MedPath

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire

Phase 3
Completed
Conditions
Malaria
Interventions
Device: Indoor residual sprayings
Device: Larvicide
Behavioral: BCC
Registration Number
NCT03074435
Lead Sponsor
Institut de Recherche pour le Developpement
Brief Summary

This study evaluates the benefit to use 1) insecticide residual sprayings, 2) larvicides, 3) Ivermectin for domestic animals and 4) behaviour change communication strategy to complement the universal coverage with LLINs through a cluster randomized trial.

Detailed Description

Insecticidal paint comprised of two organophosphates (OPs) and an Insect Growth Regulator (IGR). This tool targets adult mosquitoes that are resistant pyrethroids to reduce vector density.

Larvicide is a new formulation of Bacillus thuringiensis israelensis that will be implemented in major permanent breeding sites with the objective to reduce vector density.

Ivermectin will be injected to domestic animals in addition to the national campaign implemented in the study area which treats the whole population. Ivermectin reduces the survival of mosquito that blood feed on treated humans and animals.

Information, Education and Communication strategy aims to increase the adherence of the population to control tools available. Strengthening the IEC aims to increase the good use of long lasting nets.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15776
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LLIN + indoor residual sprayingsIndoor residual sprayingsLLIN+IRS arm consisted in applying, in addition to LLINs, IRS with Actellic® 300CS (Syngenta AG, Basel, Switzerland) at a target dosage of 1 g. of active ingredient (pirimiphos-methyl) per m² in every houses of the selected villages. This arm is common to both countries (Burkina Faso and Côte d'Ivoire)
LLIN + LarvicideLarvicideThe intervention consists in treating Anopheles breeding sites with BTI biological larvicide, in addition to LLINs. This arm was implemented in Côte d'Ivoire only.
LLIN + Behaviour Change CommunicationBCCBCC complementary intervention (LLIN+BCC arm) was designed to target the following behaviors in the human population: (i) everyone sleep under an LLIN every night, (ii) every household and community member cleans up its environment to limits mosquito proliferation, (iii) every pregnant woman asks for, and takes the intermittent preventive treatment of malaria during pregnancy (ITP) and, (iv) people in charge of \<5 y/o children come to see an health worker within 24h in case of fever. The intervention involve one health worker from the community per 35 households. Every health worker has the objective to perform 15 home visits (15-20 min), 20 interpersonal talks (15-20 min) and 4 group talks (15-30 min) per months.
LLIN+ One-health IvermectinIvermectinThis arm consists in monthly injections of ivermectin to peri-domestic farm animals (mammals) during 4 consecutive months, oin addition to LLINs. This arm was implemented in Burkina Faso only.
Primary Outcome Measures
NameTimeMethod
Malaria incidence densitycontinuous monitoring during 2 years

Malaria cases (whole population, every ages) registered in the local health system.

Secondary Outcome Measures
NameTimeMethod
Entomological Inoculation RateEvery 8 weeks during 2 years

Number of infectious bites/personn

Malaria prevalenceEvery 4 months during 2 years

% of positive blood smears among the 0-18 y/o population as recorded during cross sectional surveys.

Trial Locations

Locations (2)

Institut de Recherche en Sciences de la Santé

🇧🇫

Bobo-Dioulasso, Burkina Faso

Institut Pierre Richet

🇨🇮

Bouaké, Côte D'Ivoire

© Copyright 2025. All Rights Reserved by MedPath